Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yutaka Oguma is active.

Publication


Featured researches published by Yutaka Oguma.


Thrombosis Research | 1990

Clinical effect of low molecular weight heparin (Fragmin) on DIC : A multicenter cooperative study in Japan

Yutaka Oguma; Nobuo Sakuragawa; Masahiro Maki; Masao Nakagawa; Hiroshi Hasegawa

A multicenter cooperative study was carried out involving 47 nationwide institutes in Japan to assess the efficacy and safety of low molecular weight heparin (Fragmin) on DIC. Fifty-six DIC cases were challenged by Fragmin injection principally for 5 days with the doses of 75 U/kg/day in the I group (n = 27) and 150 U/kg/day in the II group (n = 29). Scoring points were defined based on the severity of bleeding symptoms, organ failures and abnormal coagulation-fibrinolytic examinations, and therapeutic effect of Fragmin was evaluated objectively according to the improvement degrees of these scores. Six cases (10.7%) died of the underlying diseases or complications other than DIC and hemorrhagic side effects occurred in 3.7 and 10.3% cases of the I and II groups, respectively. However, in bleeding symptoms, 45.5 and 31.6% cases of the I and II groups improved excellently or moderately. In organ failures and coagulation-fibrinolytic examinations, remarkable improvement was observed in 31.6 and 66.7% cases of the I group, while they remained 14.3 and 51.7% in the II group, respectively. The overall utility of Fragmin was 66.7% in the I group and 58.6% in the II group. These results demonstrate that Fragmin is effective on DIC with a dose of 75 U/kg/day.


Thrombosis Research | 1990

Heparin enhances thrombin-stimulated prostaglandin I2 production by cultured endothelial cells

Fumiaki Itoh; Toshiyuki Kaji; Yumiko Hayakawa; Yutaka Oguma; Nobuo Sakuragawa

Endothelial cells from human umbilical vein were incubated in vitro with thrombin in the absence or presence of unfractionated heparin (UFH), low molecular weight heparin (LMWH) or dermatan sulfate (DS) to clarify the effect of these glycosaminoglycans on thrombin-stimulated prostaglandin I2 (PGI2) production. Although DS did not affect the thrombin stimulation, UFH and LMWH each enhanced it about 1.5-fold. Pretreatment of cells with either UFH or LMWH also enhanced the thrombin stimulation. In addition, UFH and LMWH each enhanced PGI2 production stimulated by calcium ionophore A23187, but did not affect that stimulated by arachidonic acid. From these results, it was suggested that UFH and LMWH might cause a physical change of cell membrane, which would caused an easier liberation of arachidonic acid by phospholipases.


Thrombosis Research | 1992

The antithrombin III gene polymorphism in Japan: Examination for haplotypes relevant to disordered antithrombin III biosynthesis

Yutaka Oguma; Nobuo Sakuragawa; Koichi Hiraga


Japanese Journal of Thrombosis and Hemostasis | 1984

Inhibitory effect of heparin on experimental DIC induced by tissue thromboplastin

Yutaka Oguma; Hiroshi Hasegawa; Hideaki Takei; Hiroshi Nagata; Yoshikazu Kawakami


Japanese Journal of Thrombosis and Hemostasis | 1983

Measurement of Bβ 15-42 peptide (1)

Toshio Murakoshi; Hideaki Takei; Yutaka Oguma; Masao Yamauchi; Hiroshi Nagata; Hiroshi Hasegawa


Japanese Heart Journal | 1982

Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.

Hiroshi Hasegawa; Hiroshi Nagata; Masao Yamauchi; Toshio Murakoshi; Yutaka Oguma; Hideaki Takei; Tsukasa Seya; Makoto Murao


Thrombosis and Haemostasis | 1981

Easma Fibrinopeptide A And β-Thrombogloblin In The Patients With Thrombotic Disorders

Toshio Murakoshi; Hideaki Takei; Tsukasa Seya; Yutaka Oguma; Masao Yamauchi; Hiroshi Hasegawa


Japanese Heart Journal | 1980

Assay of Heparin in Plasma Using a Chromogenic Substrate and Its Clinical Applications

Hiroshi Hasegawa; Yutaka Oguma; Hideaki Takei; Tsukasa Seya; Masao Yamauchi; Toshio Murakoshi; Hiroshi Nagata; Makoto Murao


新潟医学会雑誌 | 1991

低分子ヘパリン(FR-860)のDICに対する臨床効果

豊 小熊; 信男 桜川; 雅夫 中川; 淳 長谷川; 正博 真木; Yutaka Oguma; Nobuo Sakuragawa; Masao Nakagawa; Hiroshi Hasegawa; Masahiro Maki


Japanese Circulation Journal-english Edition | 1988

An evaluation of fibrinolytic therapy of pulmonary thromboembolism using non-invasive examinations and the relationship of urokinase dosage to clinical outcome and coagulation-fibrinolytic changes.

Yutaka Oguma; Hiroshi Hasegawa; Yoshikazu Kawakami

Collaboration


Dive into the Yutaka Oguma's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge